Publication|Articles|August 21, 2025
- Pharmaceutical Executive: August 2025
- Volume 45
- Issue 6
Pharmaceutical Executive: August 2025 Interactive Digital Edition
View the Pharmaceutical Executive August 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
3 months ago
The CAR-T Climb3 months ago
2025 Emerging Pharma Leaders3 months ago
An RNA-Guided Path3 months ago
Acceleration and Ambition3 months ago
Driving Disruption in Delivery3 months ago
Building Promise from Precision3 months ago
Determined Problem-Solver3 months ago
How to Get Product Iteration Right in HealthcareNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Not Planning Increased Proposal Offer After Metsera Enters $10 Billion Amended Merger Agreement with Pfizer
2
Pharma Partnerships Expand as Eli Lilly Announces Strategic Collaborations with MeiraGTx and SanegeneBio
3
Wegovy Demonstrates Reduction in Liver Injury in MASH Patients
4
Pharmaceutical Executive Daily: FDA Approves Darzalex Faspro
5
